{
    "clinical_study": {
        "@rank": "116080", 
        "arm_group": [
            {
                "arm_group_label": "Physiotherapy", 
                "arm_group_type": "Experimental", 
                "description": "Physiotherapy included  joint protection strategies, performance of therapeutic exercises and patient education."
            }, 
            {
                "arm_group_label": "Wait list control", 
                "arm_group_type": "Other", 
                "description": "Wait list control received standard care and were invited to join the physiotherapy once intervention period is finished."
            }
        ], 
        "brief_summary": {
            "textblock": "Despite leading cause of morbidity,  treatment strategies for Rheumatic diseases are geared\n      almost exclusively toward medical-pharmacological area away from offering the patient the\n      possibility of an interdisciplinary approach to their disease.\n\n      Present study test whether treatment of physiotherapy reduces stiffness and pain inherent in\n      rheumatic disease and improve their quality of life related to health."
        }, 
        "brief_title": "Efficacy of Physiotherapy on the Health and Quality of Life of the Rheumatic Patient", 
        "completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Rheumatic Arthritis", 
        "condition_browse": {
            "mesh_term": [
                "Arthritis", 
                "Arthritis, Rheumatoid", 
                "Rheumatic Diseases", 
                "Rheumatic Fever"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients older than 18 years\n\n          -  History of Rheumatoid Arthritis (RA) symptoms for less than 7 years\n\n          -  Had RA by American College of Rheumatology (ACR) criteria\n\n          -  ACR functional RA class I, II or III\n\n          -  Hemoglobin more than 8g/dL without evidence of active bleeding\n\n          -  Positive for rheumatoid factor (RF)  or anti cyclic citrullinated protein\n\n          -  standard conventional medicine were allowed within the approved dosage regimen\n\n        Exclusion Criteria:\n\n          -  connective tissue disease\n\n          -  any other alternative or complementary medicine with in last 3 months.\n\n          -  corticosteroid, disease modifying medicines\n\n          -  Poorly controlled diabetes, hypertension, hepatitis, cardiac disease, liver diseases,\n             carcinoma, drug abuse"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "65 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "82", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 19, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02020668", 
            "org_study_id": "Mac/NMP 1210"
        }, 
        "intervention": [
            {
                "arm_group_label": "Physiotherapy", 
                "intervention_name": "Physiotherapy", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": "Wait list control", 
                "intervention_name": "Wait list control", 
                "intervention_type": "Other"
            }
        ], 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "Pain", 
            "Functional capacity", 
            "Quality of Life"
        ], 
        "lastchanged_date": "May 6, 2014", 
        "location": {
            "contact": {
                "last_name": "Deepika Ratan", 
                "phone": "9413623113"
            }, 
            "facility": {
                "address": {
                    "city": "Sikar", 
                    "country": "India", 
                    "state": "Rajasthan"
                }, 
                "name": "Life Line Hospital"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "India"
        }, 
        "number_of_arms": "2", 
        "official_title": "Phase II Study of Physiotherapy in Rheumatoid Arthritis: Randomized Single Blind Wait-list Controlled Trial", 
        "other_outcome": {
            "measure": "Functional capacity", 
            "safety_issue": "No", 
            "time_frame": "Change from baseline in Barthel Index at 16 weeks"
        }, 
        "overall_contact": {
            "email": "shekhawatvans21@gmail.com", 
            "last_name": "Virendra Shekhawat, MA", 
            "phone": "+91-8824260512"
        }, 
        "overall_official": [
            {
                "affiliation": "Macmillan Research Group", 
                "last_name": "Neha Sharma, PhD", 
                "role": "Study Director"
            }, 
            {
                "affiliation": "Life Line Hospital, Sikar, India", 
                "last_name": "Om Prakash Sharma, MBBS", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "India: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "September 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Pain", 
            "safety_issue": "No", 
            "time_frame": "Change from baseline in  Numerical Scale Downie at 16 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02020668"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "measure": "Quality of Life", 
            "safety_issue": "No", 
            "time_frame": "Change from Baseline in Short Form (SF) 36 at 16 weeks"
        }, 
        "source": "Macmillan Research Group UK", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "NMP Medical Research Institute", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Warwick Research Services", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "Macmillan Research Group UK", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "May 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}